Example: Heart Attack

Search clinical trials for: Carmustine

Total 231 results

NCT04222062

Recruiting

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Conditions: Brain Tumor - Metastatic
NCT01656980

Unknown status

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma

Conditions: Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; Glioblastoma
NCT01692691

Terminated

Dacarbazine and Carmustine in Metastatic Melanoma

Conditions: Melanoma Metastatic
NCT01637753

Unknown status

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Conditions: Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma; Glioblastoma
NCT00961220

Completed

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

Conditions: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7; Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7
NCT00362921

Completed

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

Conditions: Recurrent Adult Brain Tumor
NCT00525590

Completed

Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

Conditions: Metastatic Brain Cancer
NCT01969435

Completed

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

Conditions: Hodgkin Disease; Lymphoma, Non-Hodgkin
NCT01310868

Completed

Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma

Conditions: Glioblastoma
NCT02348255

Withdrawn

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Conditions: Adult Brain Glioblastoma; Recurrent Adult Brain Neoplasm
NCT00005961

Completed

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

Conditions: Melanoma (Skin)
NCT01186406

Terminated

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Conditions: Glioblastoma Multiforme; Gliosarcoma
NCT00003613

Terminated

O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma

Conditions: Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma
NCT03722355

Completed

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Conditions: Glioma; Glioblastoma Multiforme; Astrocytoma
NCT00814593

Withdrawn

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Conditions: Brain and Central Nervous System Tumors
NCT00795665

Completed

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Conditions: Glioma
NCT00004028

Completed

Carmustine in Treating Patients With Recurrent Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00005066

Completed

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Conditions: Sarcoma
NCT00735436

Terminated

A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)

Conditions: Malignant Glioma; Glioblastoma Multiforme; Gliosarcoma
NCT00003467

Completed

Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00003765

Completed

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Conditions: Brain and Central Nervous System Tumors
NCT00003876

Completed

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00004072

Completed

O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma

Conditions: Multiple Myeloma and Plasma Cell Neoplasm
NCT03570983

Recruiting

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

Conditions: Multiple Myeloma
NCT00574964

Terminated

Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme

Conditions: Primary Glioblastoma Multiforme